Here is key legislation that was passed in 2024 benefiting sickle cell patients living in Virginia.
HB 255 – Adult Wellness Screening for Sickle Cell Disease
Summary: This bill mandates that every adult in the Commonwealth may be offered screening tests for sickle cell disease or the sickle cell trait as part of their annual health examination. It also requires healthcare professionals to provide education and appropriate counseling regarding the results of any such test.
Impact: Increases early detection and awareness of sickle cell traits, which can lead to early management and prevention of complications.
HB 257 – Sickle Cell Anemia; Prescription of Opioids for Pain Management
Summary: This legislation exempts prescribers from certain requirements of the Prescription Monitoring Program when prescribing opioids for pain management related to sickle cell anemia.
Impact: Facilitates easier access to necessary pain management medications for individuals suffering from sickle cell disease, improving their quality of life.
HB 820 – Sickle Cell Disease; Annual Review of Medication and Treatment
Summary: Directs the Department of Medical Assistance Services to conduct an annual review of all medications and forms of treatment for sickle cell disease covered under the state plan for medical assistance services. Requires an annual report of findings and recommendations to be submitted to key legislative health committees.
Impact: Ensures ongoing evaluation and improvement of the treatments available to sickle cell patients, promoting better health outcomes.
For more details, visit Virginia’s Legislative Information System (LIS) Is a website that provides access to bills, resolutions, amendments, and other legislative documents. You can search by keyword, bill number, or subject.
